Europe GMP Cell Banking Market was valued at USD 1.6 Billion in 2022 and is projected to reach USD 3.6 Billion by 2030, growing at a CAGR of 13.6% from 2024 to 2030.
The Europe GMP Cell Banking Market is rapidly evolving, driven by increasing demand across a range of industries, including pharmaceuticals, biotechnology, and regenerative medicine. Good Manufacturing Practice (GMP) standards are essential for ensuring the highest quality in the production of cell lines used in therapies, diagnostics, and research. This market has been significantly shaped by regulatory standards, technological advancements, and the growing need for therapeutic solutions that rely on stem cells, gene therapy, and other biological products.
The growing reliance on biologics has necessitated the establishment of high-quality cell banks that comply with stringent GMP regulations. The GMP Cell Banking Market in Europe caters to this increasing demand by providing a controlled environment for the creation, preservation, and distribution of cell lines for use in therapeutic applications. These cell banks offer solutions for both master cell banks (MCBs) and working cell banks (WCBs), which are pivotal in the production of biologic medicines.
Industries such as biotechnology and pharmaceutical companies are keen on utilizing GMP-certified cell banks as they play a vital role in reducing risks associated with contamination and ensuring that the cells used in production are of the highest possible quality. This is crucial for maintaining consistency, safety, and efficacy in the final therapeutic products. Furthermore, regulatory bodies across Europe mandate the use of GMP-compliant facilities for cell banking processes, which further drives the demand in this market.
In terms of market types, the Europe GMP Cell Banking Market can be segmented based on service offerings, including cell banking, storage services, and cell line development. Each of these services plays a significant role in ensuring that biologics reach their full therapeutic potential while complying with stringent regulatory standards. Companies and research institutions are looking for reliable partners who can deliver these services efficiently and cost-effectively.
The requirement for GMP cell banking is also fueled by innovations in regenerative medicine, gene therapy, and personalized medicine. The need for creating customized treatments, especially in cancer immunotherapy and cell-based therapies, has amplified the demand for secure, high-quality cell banking solutions. This shift is expected to drive growth in the Europe GMP Cell Banking Market over the coming years.
The evolving regulations and the focus on expanding the healthcare sector in Europe will likely continue to propel the need for GMP-compliant cell banking solutions, as well as related services. Industries relying on advanced technologies such as stem cell research and biopharmaceuticals will increasingly require access to GMP-certified cell banks to ensure product safety, efficacy, and regulatory compliance.
Get an In-Depth Research Analysis of the Europe GMP Cell Banking Market Size And Forecast [2025-2032]
WuXi AppTec
Charles River Laboratories International
Eurofins Scientific
Merck KGaA
Lonza Group Ltd
SGS Ltd
ViruSure GmbH
Austrianova
Goodwin Biotechnology Inc
Paragon Bioservices
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe GMP Cell Banking Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe GMP Cell Banking Market
Embryonic Stem Cells (ESCs)
Induced Pluripotent Stem Cells (iPSCs)
Adult Stem Cells
Mesenchymal Stem Cells (MSCs)
Hematopoietic Stem Cells
Standard Cell Banks
Customized Cell Banks
Pre-clinical Cell Banks
Clinical Cell Banks
Commercial Cell Banks
Regenerative Medicine
Cellular Therapy
Tissue Engineering
Research & Development
Drug Discovery and Development
Biotechnology Companies
Pharmaceutical Companies
Academic & Research Institutes
Contract Research Organizations (CROs)
Hospitals and Diagnostic Centers
CrYopreservation
Cell Banking in Resource-Rich Media
Short-term Cell Storage
Long-term Cryogenic Storage
Surface Media Storage
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ GMP Cell Banking Market Research Analysis
1. Introduction of the Europe GMP Cell Banking Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe GMP Cell Banking Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe GMP Cell Banking Market, By Type
6. Europe GMP Cell Banking Market, By Application
7. Europe GMP Cell Banking Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe GMP Cell Banking Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/